BetterHelp competes for services previously driven by Teladoc, while both companies face market headwinds.
4 reports, 3 independent
Updated Sep 5
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 7
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BetterHelp competes for services previously driven by Teladoc, while both companies face market headwinds.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Competitors copied BetterHelp's successful service format, and Teladoc announced it has integrated BetterHelp as a core service offering.Sub-event
- Teladoc granted stock units for a role at BetterHelp.Sub-event
- Insurance coverage is helping BetterHelp users.Sub-event
- BetterHelp is leveraging the acquisition of Uplift to improve conversion rates and market standing, with market presentations highlighting strong growth prospects.Sub-event
- Wellbound EAP provides online therapy services through BetterHelp.Sub-event
- BetterHelp segment is facing slowing revenue and declining users as of July 31, 2025.Sub-event
BetterHelp competes for services previously driven by Teladoc, while both companies face market headwinds.1 source
Keep exploring
The entities involved
-
Teladoc
American healthcare company
-
BetterHelp
virtual counceling and therapy service company
Nothing else this week.
-
Sarepta Therapeutics
biopharmaceutical company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Motley Fool2 Beaten-Down Stocks to Avoid Right Now Teladoc faces slow revenue growth (at best), constant net losses, and steep competition. Sarepta Therapeutics' most important product, a gene therapy, is under
- Motley Fool2 Stocks Down More Than 90% That Still Aren't Worth Buying Teladoc Health and Tilray Brands have lost significant value over the past five years. Teladoc is posting slow growth and consistent net los
- StockStoryTDOC Q2 Deep Dive: Insurance Transition and Product Expansion Shape Outlook Digital medical services platform Teladoc Health (NYSE:TDOC) beat Wall Street’s revenue expectations in Q2 CY2025, but sale
- Healthcare DiveTeladoc to launch employee assistance program This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Tela